Yahoo
NSE - Delayed Quote INR

Neogen Chemicals Limited (NEOGEN.NS)

2,171.40 -90.30 (-3.99%)
At close: October 30 at 3:30:01 PM GMT+5:30
NEOGEN.NS Q2 2027 earnings call
November 2, 2026 at 5:00 PM GMT+5:30
Chart Range Bar
Loading chart for NEOGEN.NS
  • Previous Close 2,261.70
  • Open 2,270.00
  • Bid --
  • Ask --
  • Day's Range 2,158.90 - 2,270.00
  • 52 Week Range 966.70 - 2,785.00
  • Volume 77,054
  • Avg. Volume 212,499
  • Market Cap (intraday) 65.234B
  • Beta (5Y Monthly) 0.73
  • PE Ratio (TTM) 163.39
  • EPS (TTM) 13.29
  • Earnings Date (est.) --
  • Forward Dividend & Yield 1.00 (0.05%)
  • Ex-Dividend Date Aug 13, 2026
  • 1y Target Est 2,288.36

Neogen Chemicals Limited engages in the manufacture and sale of specialty chemicals in India. It offers organo bromine compounds, such as alkyl bromide compounds, dibromoalkane compounds, bromo chloro alkanes, bromine derivatives of organoacids, bromoacid ester compounds, aromatic bromine derivatives, cyclic bromine derivatives, and speciality bromo fluro derivatives; speciality chloro compounds comprising unsaturated bromine derivatives, bromo hydroxy derivatives, and other compounds; and organo lithium compounds, including n-butyl lithium, lithium hexamethyldisilazide, lithium tetrahydride borate, lithium diisopropylamide, lithium tri-(t-butoxy) aluminium hydride, hexyl lithium, methyl lithium, and phenyl lithium. The company also provides inorganic chemicals comprising inorganic bromine compounds and lithium salts; grignard reagents; advance intermediates; and chemistries, such as alkylation, amination, oxidation, dehalogenation, silylation, anhydrous HF and HBr reactions, halex reaction, suzuki coupling, hydrogenation, and biocatalysis. It serves pharmaceuticals, agrochemicals, electronics, water treatment, construction, polymers, flavours & fragrances and energy storage. The company also exports its products to 36 countries. Neogen Chemicals Limited was incorporated in 1989 and is based in Thane, India.

www.neogenchem.com

680

Full Time Employees

March 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

NEOGEN.NS
83.45%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

NEOGEN.NS
48.30%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

NEOGEN.NS
37.82%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

NEOGEN.NS
83.97%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 2.96B
Earnings 82.3M
Profit Margin 2.78%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
1B
2B
2.0%
3.0%
4.0%
5.0%
6.0%

Analyst Insights

View More

Analyst Price Targets

1,455.00 Low
2,288.36 Average
2,171.40 Current
3,050.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.85%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.26B

  • Net Income Avi to Common (ttm)

    356M

  • Diluted EPS (ttm)

    13.29

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    49.5M

  • Total Debt/Equity (mrq)

    170.91%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: